237 related articles for article (PubMed ID: 22179830)
1. Blocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-mediated apoptosis of cancer cells.
Casar B; He Y; Iconomou M; Hooper JD; Quigley JP; Deryugina EI
Oncogene; 2012 Aug; 31(35):3924-38. PubMed ID: 22179830
[TBL] [Abstract][Full Text] [Related]
2. In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling.
Casar B; Rimann I; Kato H; Shattil SJ; Quigley JP; Deryugina EI
Oncogene; 2014 Jan; 33(2):255-68. PubMed ID: 23208492
[TBL] [Abstract][Full Text] [Related]
3. Proteolysis-induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKCdelta.
He Y; Wortmann A; Burke LJ; Reid JC; Adams MN; Abdul-Jabbar I; Quigley JP; Leduc R; Kirchhofer D; Hooper JD
J Biol Chem; 2010 Aug; 285(34):26162-73. PubMed ID: 20551327
[TBL] [Abstract][Full Text] [Related]
4. Novel small molecule inhibiting CDCP1-PKCδ pathway reduces tumor metastasis and proliferation.
Nakashima K; Uekita T; Yano S; Kikuchi JI; Nakanishi R; Sakamoto N; Fukumoto K; Nomoto A; Kawamoto K; Shibahara T; Yamaguchi H; Sakai R
Cancer Sci; 2017 May; 108(5):1049-1057. PubMed ID: 28256037
[TBL] [Abstract][Full Text] [Related]
5. Suppression of autophagy by CUB domain-containing protein 1 signaling is essential for anchorage-independent survival of lung cancer cells.
Uekita T; Fujii S; Miyazawa Y; Hashiguchi A; Abe H; Sakamoto M; Sakai R
Cancer Sci; 2013 Jul; 104(7):865-70. PubMed ID: 23510015
[TBL] [Abstract][Full Text] [Related]
6. Functional role of cell surface CUB domain-containing protein 1 in tumor cell dissemination.
Deryugina EI; Conn EM; Wortmann A; Partridge JJ; Kupriyanova TA; Ardi VC; Hooper JD; Quigley JP
Mol Cancer Res; 2009 Aug; 7(8):1197-211. PubMed ID: 19671673
[TBL] [Abstract][Full Text] [Related]
7. KAI1 suppresses HIF-1α and VEGF expression by blocking CDCP1-enhanced Src activation in prostate cancer.
Park JJ; Jin YB; Lee YJ; Lee JS; Lee YS; Ko YG; Lee M
BMC Cancer; 2012 Mar; 12():81. PubMed ID: 22390300
[TBL] [Abstract][Full Text] [Related]
8. CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma.
Uekita T; Jia L; Narisawa-Saito M; Yokota J; Kiyono T; Sakai R
Mol Cell Biol; 2007 Nov; 27(21):7649-60. PubMed ID: 17785447
[TBL] [Abstract][Full Text] [Related]
9. Src Kinase Is Biphosphorylated at Y416/Y527 and Activates the CUB-Domain Containing Protein 1/Protein Kinase C δ Pathway in a Subset of Triple-Negative Breast Cancers.
Nelson LJ; Wright HJ; Dinh NB; Nguyen KD; Razorenova OV; Heinemann FS
Am J Pathol; 2020 Feb; 190(2):484-502. PubMed ID: 31843498
[TBL] [Abstract][Full Text] [Related]
10. CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis.
Liu H; Ong SE; Badu-Nkansah K; Schindler J; White FM; Hynes RO
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1379-84. PubMed ID: 21220330
[TBL] [Abstract][Full Text] [Related]
11. CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation.
Miyazawa Y; Uekita T; Hiraoka N; Fujii S; Kosuge T; Kanai Y; Nojima Y; Sakai R
Cancer Res; 2010 Jun; 70(12):5136-46. PubMed ID: 20501830
[TBL] [Abstract][Full Text] [Related]
12. Adhesion or plasmin regulates tyrosine phosphorylation of a novel membrane glycoprotein p80/gp140/CUB domain-containing protein 1 in epithelia.
Brown TA; Yang TM; Zaitsevskaia T; Xia Y; Dunn CA; Sigle RO; Knudsen B; Carter WG
J Biol Chem; 2004 Apr; 279(15):14772-83. PubMed ID: 14739293
[TBL] [Abstract][Full Text] [Related]
13. CDCP1 promotes compensatory renal growth by integrating Src and Met signaling.
Kajiwara K; Yamano S; Aoki K; Okuzaki D; Matsumoto K; Okada M
Life Sci Alliance; 2021 Apr; 4(4):. PubMed ID: 33574034
[TBL] [Abstract][Full Text] [Related]
14. Cellular settings mediating Src Substrate switching between focal adhesion kinase tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) tyrosine 734.
Wortmann A; He Y; Christensen ME; Linn M; Lumley JW; Pollock PM; Waterhouse NJ; Hooper JD
J Biol Chem; 2011 Dec; 286(49):42303-42315. PubMed ID: 21994943
[TBL] [Abstract][Full Text] [Related]
15. SRC kinase activator CDCP1 promotes hepatocyte growth factor-induced cell migration/invasion of a subset of breast cancer cells.
Kawase N; Sugihara A; Kajiwara K; Hiroshima M; Akamatsu K; Nada S; Matsumoto K; Ueda M; Okada M
J Biol Chem; 2022 Mar; 298(3):101630. PubMed ID: 35085554
[TBL] [Abstract][Full Text] [Related]
16. CUB domain-containing protein 1 (CDCP1) binds transforming growth factor beta family members and increase TGF-β1 signaling pathway.
Predes D; Cruz JVR; Abreu JG; Mendes FA
Exp Cell Res; 2019 Oct; 383(1):111499. PubMed ID: 31302030
[TBL] [Abstract][Full Text] [Related]
17. CDCP1 cleavage is necessary for homodimerization-induced migration of triple-negative breast cancer.
Wright HJ; Arulmoli J; Motazedi M; Nelson LJ; Heinemann FS; Flanagan LA; Razorenova OV
Oncogene; 2016 Sep; 35(36):4762-72. PubMed ID: 26876198
[TBL] [Abstract][Full Text] [Related]
18. Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer.
Harrington BS; He Y; Khan T; Puttick S; Conroy PJ; Kryza T; Cuda T; Sokolowski KA; Tse BW; Robbins KK; Arachchige BJ; Stehbens SJ; Pollock PM; Reed S; Weroha SJ; Haluska P; Salomon C; Lourie R; Perrin LC; Law RHP; Whisstock JC; Hooper JD
Theranostics; 2020; 10(5):2095-2114. PubMed ID: 32104500
[TBL] [Abstract][Full Text] [Related]
19. CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment.
Law ME; Ferreira RB; Davis BJ; Higgins PJ; Kim JS; Castellano RK; Chen S; Luesch H; Law BK
Breast Cancer Res; 2016 Aug; 18(1):80. PubMed ID: 27495374
[TBL] [Abstract][Full Text] [Related]
20. Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy.
Kollmorgen G; Niederfellner G; Lifke A; Spohn GJ; Rieder N; Harring SV; Bauss F; Burtscher H; Lammers R; Bossenmaier B
Mol Oncol; 2013 Dec; 7(6):1142-51. PubMed ID: 24055141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]